Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge

Annals of Allergy, Asthma and Immunology

Volumn 113, Issue 4, 2014, Pages 476-481

  Fujishima, Hiroshi ^a   Ohashi, Yuichi ^b   Takamura, Etsuko ^c  

^a TSURUMI UNIVERSITY   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPINASTINE; EYE DROPS; OLOPATADINE; PLACEBO; POLLEN ANTIGEN; ALLERGEN; ANTIALLERGIC AGENT; ANTITHROMBOCYTIC AGENT; DIBENZAZEPINE DERIVATIVE; DIBENZOXEPIN DERIVATIVE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMIDAZOLE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CONJUNCTIVAL HYPEREMIA; CONJUNCTIVITIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCULAR PRURITUS; PHARYNX DISCOMFORT; PHASE 3 CLINICAL TRIAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SEASONAL ALLERGIC CONJUNCTIVITIS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; URTICARIA; VOLUNTEER; WOUND; CEDRUS; CLINICAL TRIAL; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; HYPEREMIA; IMMUNOLOGY; MIDDLE AGED; POLLEN; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

ADULT; ALLERGENS; ANTI-ALLERGIC AGENTS; CEDRUS; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; DIBENZAZEPINES; DIBENZOXEPINS; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYPEREMIA; IMIDAZOLES; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PLATELET AGGREGATION INHIBITORS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

EID: 84908478807     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.07.007     Document Type: Article

References (20)

1. E. Takamura, E. Uchio, and N. Ebihara Japanese guideline for allergic conjunctival diseases Allergol Int 60 2011 191 203
2. M.B. Abelson Comparison of the conjunctival allergen challenge model with the environmental model of allergic conjunctivitis Acta Opthalmol Scand Suppl 228 1999 38 42
3. M.B. Abelson, W.A. Chambers, and L.M. Smith Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis Arch Ophthalmol 108 1990 84 88
4. M.B. Abelson, A. Paradis, M.A. George, L.M. Smith, L. Maguire, and R. Burns Effects of Vasocon-A in the allergen challenge model of acute allergic conjunctivitis Arch Ophthalmol 108 1990 520 524
5. M.B. Abelson, and O. Loeffler Conjunctival allergen challenge: models in the investigation of ocular allergy Curr Allergy Asthma Rep 3 2003 363 368
6. J.I. Williams, K.S. Kennedy, and J.A. Gow Prolonged effectiveness of Bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis J Ocul Pharmacol Ther 27 2011 385 393
7. G. Torkildsen, and A. Shedden The safety and efficacy of alcaftadine 0.25% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis Curr Med Res Opin 27 2011 623 631
8. E. Takamura, K. Nomura, and H. Fujishima Efficacy of levocabastine hydrochloride ophthalmic suspension in the conjunctival allergen challenge test in Japanese subjects with seasonal allergic conjunctivitis Allergol Int 55 2006 157 165
9. A. Fügner, W.D. Bechtel, F.J. Kuhn, and J. Mierau In vitro and in vivo studies of the non-sedating antihistamine epinastine Arzneimittelforschung 38 1988 1446 1453
10. K. Tasaka, M. Akagi, K. Izushi, and I. Aoki Antiallergic effect of epinastine: the elucidation of the mechanism Pharmacometrics 39 1990 365 373
11. N. Matsushita, K. Aritake, and A. Takada Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects Jpn J Pharmacol 78 1998 11 22
12. C. Kamei, M. Mio, and K. Kitazumi Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II) antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects Immunopharmacol Immunotoxicol 14 1992 207 218
13. M.B. Abelson, P. Gomes, H.J. Crampton, R.M. Schiffman, R.R. Bradford, and S.M. Whitcup Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis Clin Ther 26 2004 35 47
14. M. Okuda Epidemiology of Japanese cedar pollinosis throughout Japan Ann Allergy Asthma Immunol 91 2003 288 296
15. K. Baba, and K. Nakae National epidemiological survey of nasal allergy 2008 (compared with 1998) in otolaryngologists and their family members Prog Med 28 2008 2001 2012 (in Japanese)
16. K. Okubo, Y. Kurono, and S. Fujieda Japanese guideline for allergic rhinitis Allergol Int 60 2011 171 189
17. M.T. Irkec, and B. Bozkurt Molecular immunology of allergic conjunctivitis Curr Opin Allergy Clin Immunol 12 2012 534 539
18. B.P. Bielory, T.P. O'Brien, and L. Bielory Management of seasonal allergic conjunctivitis: guide to therapy Acta Ophthalmol 90 2012 399 407
19. S.M. Whitcup, R. Bradford, J. Lue, R.M. Schiffman, and M.B. Abelson Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis Clin Ther 26 2004 29 34
20. M. Borazan, A. Karalezli, Y.A. Akova, A. Akman, H. Kiyici, and S.S. Erbek Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial Acta Ophthalmol 87 2009 549 554